Last reviewed · How we verify
Severe chronic obstructive pulmonary disease
Approved treatments
- Daliresp · Arcutis
Daliresp works by blocking an enzyme called phosphodiesterase 4, which helps reduce inflammation in the body. - Foradil · Novartis
Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing. - Pulmicort Respules · AstraZeneca K.K.
- Daxas · AstraZeneca
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Severe chronic obstructive pulmonary disease patent landscape — cliff calendar, originator estates, attackable patents
- Severe chronic obstructive pulmonary disease treatment landscape brief
- Severe chronic obstructive pulmonary disease treatment updates RSS
Frequently asked questions about Severe chronic obstructive pulmonary disease
What drugs treat Severe chronic obstructive pulmonary disease?
Tracked treatments include Daliresp, Foradil, Pulmicort Respules, Daxas.
What is the treatment for Severe chronic obstructive pulmonary disease?
Standard treatment for Severe chronic obstructive pulmonary disease includes Daliresp, Foradil, Pulmicort Respules, Daxas. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Severe chronic obstructive pulmonary disease patent cliff · Severe chronic obstructive pulmonary disease CI report
- Treatment: Daliresp · Arcutis
- Treatment: Foradil · Novartis
- Treatment: Pulmicort Respules · AstraZeneca K.K.
- Treatment: Daxas · AstraZeneca
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing